Form 8 (DD) - Harworth Group plc

In brief · summary, not quotable

Peel Pepper (UK) Limited, a concert party to Harworth Group plc, disclosed dealings on September 17, 2026, involving the purchase of 197,525 ordinary shares in Harworth Group plc across various prices ranging from 1.760 GBP to 1.774 GBP. Following these transactions, Peel Pepper (UK) Limited and its concert parties collectively hold 98,105,550 Harworth Group plc shares, representing 30.00% of the company's share capital, with no short positions reported.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your HWG notes

KEY INFORMATION

(e) Date dealing undertaken:				17 September 2026
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
Class of relevant security:				10p ordinary
Interests				Short positions
Number		%	Number	%
(1) Relevant securities owned and/or controlled:	156,141*	0.05%*	Nil	Nil
(2) Cash-settled derivatives:	Nil	Nil	Nil	Nil
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:	Nil	Nil	Nil	Nil
TOTAL:	156,141*	0.05%*	Nil	Nil

*Note: As at 17 September 2026, Peel Pepper (UK) Limited and its concert parties hold in aggregate 98,105,550 shares in Harworth Group plc, which equates to 30.00% of the share capital.

All interests and all short positions should be disclosed.

Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:	N/A
Details, including nature of the rights concerned and relevant percentages:	N/A

DEALINGS BY THE PERSON MAKING THE DISCLOSURE

The currency of all prices and other monetary amounts should be stated.

Purchases and sales

				Class of relevant security	Purchase/sale	Number of securities	Price per unit
10p ordinary					Purchase	10,398	1.774 GBP
10p ordinary					Purchase	1,247	1.772 GBP
10p ordinary					Purchase	7,000	1.771 GBP
10p ordinary					Purchase	6,500	1.773 GBP
10p ordinary					Purchase	3,419	1.770 GBP
10p ordinary					Purchase	61,293	1.765 GBP
10p ordinary					Purchase	15,262	1.768 GBP
10p ordinary					Purchase	9,194	1.764 GBP
10p ordinary					Purchase	36,146	1.763 GBP
10p ordinary					Purchase	5,682	1.760 GBP
Class of relevant security				Purchases/ sales	Total number of securities	Highest price per unit paid/received	Lowest price per unit paid/received
N/A.				N/A.	N/A.	N/A.	N/A.
(b) Cash-settled derivative transactions
Class of relevant security				Product description e.g. CFD	Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position	Number of reference securities	Price per unit
N/A.				N/A.	N/A.	N/A.	N/A.
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security	Product description e.g. call option	Writing, purchasing, selling, varying etc.	Number of securities to which option relates	Exercise price per unit	Type e.g. American, European etc.	Expiry date	Option money paid/ received per unit
N/A.	N/A.	N/A.	N/A.	N/A.	N/A.	N/A.	N/A.
(ii) Exercise
Class of relevant security				Product description e.g. call option	Exercising/ exercised against	Number of securities	Exercise price per unit
N/A.				N/A.	N/A.	N/A.	N/A.
(d) Other dealings (including subscribing for new securities)
Class of relevant security					Nature of dealing e.g. subscription, conversion	Details	Price per unit (if applicable)
N/A.					N/A.	N/A.	N/A.

OTHER INFORMATION
Indemnity and other dealing arrangements

None.

Agreements, arrangements or understandings relating to options or derivatives

None.

Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions)	NO
Supplemental Form 8 (SBL)	NO
Date of disclosure:	18 September 2026

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.